[
    [
        {
            "time": "2020-01-01",
            "original_text": "2020年CDMO领域收入排行，五年内“药明生物”市占率必降 盈利能力下降",
            "features": {
                "keywords": [
                    "CDMO",
                    "药明生物",
                    "市占率",
                    "盈利能力",
                    "收入排行"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2020年CDMO领域收入排行，五年内“药明生物”市占率必降 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]